Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Open in API
Filings indexed 648 across all filing types
Latest filing 2015-12-22 Board/Management Inform…
Country SE Sweden
Listing ST GETI

About Getinge

https://www.getinge.com/int/

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
Pernille Fabricius appointed new CFO of Getinge Group
Board/Management Information Classification · 99% confidence The document is a press release dated December 22, 2015, announcing the appointment of Pernille Fabricius as the new Chief Financial Officer (CFO) and the retirement of the previous CFO, Ulf Grunander. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The filing code for this category is MANG.
2015-12-22 English
Getinge Infection Control enters into low temperature market with acquisition of Stericool and exclusive distribution agreement with TSO3
M&A Activity Classification · 95% confidence The document is a press release dated 2015-12-14 announcing a strategic business development: the acquisition of Stericool and an exclusive distribution agreement with TSO3 by Getinge Infection Control. This type of announcement, detailing corporate actions like M&A or significant commercial agreements, is typically classified as a general corporate announcement or a regulatory filing, but it does not fit the specific definitions for 10-K, ER, IR, or DIV. Since it is a specific announcement about a transaction (acquisition/partnership) that impacts the company's structure and future operations, it is most closely related to M&A Activity (TAR) or a general Regulatory Filing (RNS). Given the focus is on the acquisition and distribution agreement, TAR (Merger/Takeover Activity) is a strong candidate, although it is not a formal takeover bid. However, in many databases, significant acquisitions announced via press release fall under M&A or a general corporate action category. Since TAR is defined as 'Merger proposals or takeover bids,' and this is a completed acquisition announcement, it leans towards a general regulatory announcement. Given the options, and that it is a material corporate event announcement, RNS (Regulatory Filings - fallback) is the safest classification if TAR is strictly interpreted as only proposals/bids, but since it involves an acquisition, TAR is often used broadly. Let's re-evaluate: It is a press release announcing an acquisition and a major distribution deal. This is a material event disclosure. It is not a financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a corporate action announcement. TAR (M&A Activity) is the best fit for an acquisition announcement, even if it's not a 'bid' or 'proposal' in the hostile sense. I will classify it as TAR.
2015-12-14 English
Getinge Infection Control tar steget in på lågtemperaturmarknaden genom förvärv av Stericool samt exklusivt distributionsavtal med TSO3
M&A Activity Classification · 99% confidence The document is a press release dated December 14, 2015, announcing two significant corporate actions by Getinge Infection Control: the acquisition of Stericool and signing an exclusive global distribution agreement with TSO3 Inc. These actions relate to financing, corporate structure changes, and strategic business development (M&A activity). Since the document details the terms of an acquisition (Stericool) and a major agreement/licensing deal (TSO3), it falls under corporate financing or M&A activity. Given the specific definitions, 'Capital/Financing Update' (CAP) covers fundraising/financing activities, and 'M&A Activity' (TAR) covers merger proposals or takeover bids. An acquisition is a core component of M&A. While it involves financing, the primary event described is the acquisition and the strategic partnership/distribution agreement. 'TAR' (M&A Activity) is the most fitting category for announcing a completed acquisition and a major strategic deal, as opposed to a general financing update (CAP) or a general regulatory announcement (RNS). The document is substantial and provides details, so it is not an RPA.
2015-12-14 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-September 2015. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management commentary on business performance, market outlook, and organizational changes. It is not a short announcement, but a full quarterly report. 9M 2015
2015-10-15 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Report' for the period January – September 2015, containing detailed financial statements, tables (Order intake, Net sales, EBITA, etc.), CEO commentary, and operational updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-10-15 English
Getinges delårsrapport januari – september 2015 och telefonkonferens
Report Publication Announcement Classification · 98% confidence The document is a press release dated September 25, 2015, announcing the upcoming publication of Getinge's interim report ('delårsrapport') for January–September 2015 on October 15, 2015. It explicitly details the time, dial-in numbers, agenda, and Q&A session for the subsequent conference call, and mentions that a presentation will be held during the call. Since the document is an announcement about the release of the interim report and the associated conference call, and it is short (2012 characters), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself. The mention of the conference call details also strongly suggests a connection to the Call Transcript (CT) category, but the primary purpose here is announcing the *release* of the report and the call, making RPA the most accurate fit based on Rule 2.
2015-09-25 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.